Canadian Psychiatric Association

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)


Guest Editorial
Culture and Psychiatry, or “The Tale of the Hole and the Cheese”
Morton Beiser
(PDF)


In Review
Cultural Consultation: A Model of Mental Health Service for Multicultural Societies

Laurence J Kirmayer, Danielle Groleau, Jaswant Guzder, Caminee Blake, Eric Jarvis

(PDF)

Why Should Researchers Care About Culture?
Morton Beiser

(PDF)

Culturally Competent Psychotherapy
Hung-Tat Lo, Kenneth P Fung

(PDF)


Original Research
Spirituality and Religion in Canadian Psychiatric Residency Training

Andrea D Grabovac, Soma Ganesan

(PDF)

Are Mental Health Services for Children Distributed According to Needs?
Régis Blais, Jean-Jacques Breton, Mylène Fournier, Marie St-Georges, Claude Berthiaume

(PDF)

A Random-Assignment, Double-Blind, Clinical Trial of Once- vs Twice-Daily Administration of Quetiapine Fumarate in Patients with Schizophrenia or Schizoaffective Disorder: A Pilot Study
KN Roy Chengappa, Haranath Parepally, Jaspreet S Brar, Jamie Mullen, Ann Shilling, Jeffrey M Goldstein

(PDF)


Review Paper
Essential Fatty Acids and the Brain

Marianne Haag

(PDF)


Brief Communication
Symptom Outcome 1 Year After Admission to an Early Psychosis Program

Jean Addington, Erin Leriger, Donald Addington

(PDF)


Book Reviews
(PDF)

A Beautiful Mind.
Reviewed by
Vivian Rakoff, MA, MBBS, FRCPC

Staying Human During Residency Training. 2nd edition.
Reviewed by
Emmanuel Persad, MBBS, FRCPC


Letters to the Editor
(PDF)

La mémoire est une faculté qui oublie

Clinical and Family History Markers of Bipolar II Disorder

Re: Clinical and Family History Markers of Bipolar II Disorder

Effect of Olanzapine on the Liver Transaminases

Letters to the Editor

Re: Clinical and Family History Markers of Bipolar II Disorder

Dear Editor:

We thank Dr Benazzi for his letter. He reviews previous studies that support associations between what we call bipolar spectrum disorder (BSD) and early-onset, atypical features, and mixed mood symptoms. He also applies our proposed definition to its first empirical test and finds excellent sensitivity for recurrent depressive episodes (3 or more), together with good specificity for atypical depressive features and mixed mood symptoms. We appreciate Dr Benazzi’s careful empirical assessment. This is exactly the kind of empirical test that we hoped our heuristic definition of BSD would stimulate. We only hope that Dr Benazzi and other investigators will continue these studies, so that the criteria can be further refined empirically.

We wish to highlight 2 aspects of our proposal. On the one hand, we describe features of depressive symptoms, course, family history, and treatment response. We propose that these features outline a group of depression patients who have neither classic unipolar nor classic bipolar disorder (BD); that is, they never display spontaneous mania or hypomania. However, a unipolar diagnosis broad enough to encompass such patients may offer little in the way of predictive validity. These patients, in fact, have many more diagnostic features in common with BD than with unipolar depression. We therefore suggest the term BSD for this group, and we advocate empirical tests of our definition. Conversely, as Dr Benazzi also emphasizes, our proposed definition can be seen as a way of assessing patients who may be at high risk for having BD or later developing the disorder, especially BD II. If patients have many of the bipolar spectrum depressive features we highlight, closer examination may reveal past episodes of hypomania (or sometimes even mania) that either have been denied or have escaped detection. Further, such patients may be at high risk for future spontaneous hypomanic or manic episodes and thus may warrant careful assessment for such symptoms longitudinally. Hence, our list of bipolar spectrum symptoms can also be seen as clues for bipolarity that, if present, warrant an even more extensive evaluation for hypomanic or manic symptoms in a patient who does not appear to have BD.

In any case, we wish to emphasize that these are testable hypotheses, and we welcome and request the type of empirical examination that Dr Benazzi has inaugurated.

Nassir Ghaemi, MD;
James Y Ko, AB;
Frederick K Goodwin, MD
Cambridge, Massachusetts




CJP Archives in English | Archives RCP en français
Supplements and Position Paper Inserts |
Lignes directrices cliniques, énoncés de principe et communiqués
Author Index to 2002 | Index RCP des auteurs 2002
Subject Index to 2002 | Index RCP des sujets 2002
Information for Contributors | Information à l'intention des auteurs
Style Notes for Contributors
Subscription Rates | Prix d'abonnements
Advertising Rates | Tarifs publicitaires
CPA Home | Page d'accueil